| HGNC Family | Zinc fingers |
| Name | nuclear receptor subfamily 1, group I, member 3 |
| Description | This gene encodes a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. The protein binds to DNA as a monomer or a heterodimer with the retinoid X receptor and regulates the transcription of target genes involved in drug metabolism and bilirubin clearance, such as cytochrome P450 family members. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand but is regulated by both agonists and inverse agonists. Ligand binding results in translocation of this protein to the nucleus, where it activates or represses target gene transcription. These ligands include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. In addition to drug metabolism, the CAR protein is also reported to regulate genes involved in glucose metabolism, lipid metabolism, cell proliferation, and circadian clock regulation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2020] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe nuclear receptor NR1I3, commonly known as the constitutive androstane receptor (CAR), is a central regulator of hepatic xenobiotic metabolism. It mediates the induction of numerous detoxification genes, including those involved in bilirubin clearance and the metabolism of drugs such as acetaminophen, thereby contributing to hepatoprotection and, in certain cases, to the treatment of hyperbilirubinemia (e.g., neonatal jaundice). CAR’s activation in liver cells promotes the coordinated expression of phase I drug‐metabolizing cytochrome P450 enzymes and phase II conjugating enzymes, establishing a first‐line response to xenobiotic stress (see."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCAR exerts its effects in part by regulating the transcription of cytochrome P450 enzymes. It directly transactivates genes such as CYP3A4, CYP3A5, CYP2C9, and CYP2C8 by binding to specific response elements within their promoters, thereby facilitating the hepatic clearance and biotransformation of a wide array of xenobiotics and endogenous substrates (see."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its role in drug metabolism, CAR activity is modulated by inflammatory and stress‐related signals. During inflammatory states, for example, cytokines such as interleukin‐1β down‐regulate CAR expression, thereby impairing the induction of key drug–metabolizing enzymes and transporters. Moreover, endobiotic signals, including those activated by natural compounds from herbal extracts, can influence CAR‐mediated responses (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nClinical and pharmacogenomic studies have explored the impact of genetic variability in NR1I3 on drug disposition and adverse drug reactions. Investigations into single‐nucleotide polymorphisms within CAR have aimed to assess their relationship with altered drug clearance and toxicity—findings that may ultimately inform individualized therapeutic strategies (see."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its canonical function in xenobiotic detoxification, CAR is also implicated in the regulation of hepatic energy metabolism, liver growth, and even tumorigenesis. Its chronic activation can contribute to liver hypertrophy and carcinogenesis by modulating proliferative and apoptotic pathways (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCAR activity is tightly coordinated by an array of post‐translational modifications and transcriptional mechanisms. Alternative splicing generates receptor isoforms with distinct activities, while interactions with coactivators—such as PGC‑1α and HNF4α—as well as reversible phosphorylation (notably at threonine residues) regulate its nuclear translocation and DNA binding capacity. These molecular events ensure the precise control of downstream gene expression in response to both exogenous and endogenous signals (see."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "21"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nSpecies‐specific differences in ligand recognition have also been documented for CAR. For instance, the antiemetic meclizine functions as an agonist for murine CAR yet acts as an inverse agonist for its human counterpart, underscoring the importance of considering interspecies variations in CAR‐mediated responses (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCAR’s diverse regulatory functions are further enriched through cross-talk with other nuclear receptors and signaling pathways. It can antagonize estrogen receptor–mediated transcription by sequestering limiting amounts of shared coactivators, and it interferes with other transcription factors to regulate the expression of key transporters such as MRP4 and P‑glycoprotein. Such interactions contribute to multidrug resistance phenomena observed in cancer and affect drug penetration across critical barriers (see."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "26"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCooperative interactions between CAR and other transcription factors, such as ATF5, further amplify its ability to stimulate the expression of drug–metabolizing enzymes in hepatocytes, reinforcing the maintenance of liver homeostasis (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "27"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nUpstream, CAR is subjected to multifaceted regulation by environmental and hormonal cues. Networks involving microRNAs (notably miR‑122), early growth response proteins (EGR1), and PPARα signaling converge on CAR to finely tune its expression and activation status, thereby linking xenobiotic sensing to broader metabolic and developmental pathways (see."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "29", "end_ref": "32"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn specialized tissues, such as the testis, CAR also plays a role in regulating drug transporter expression at the blood–testis barrier, which may impact the distribution and efficacy of therapeutics like antiretroviral agents (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRecent genome–wide transcriptomic analyses have broadened our understanding of CAR’s transcriptional repertoire. Such studies elucidate how CAR integrates into global metabolic networks and highlight its involvement in both normal physiology and disease processes (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "34"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jun Zhang, Wendong Huang, Steven S Chua, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1073502"}], "href": "https://doi.org/10.1126/science.1073502"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12376703"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12376703"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Wen Xie, Mei-Fei Yeuh, Anna Radominska-Pandya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0438010100"}], "href": "https://doi.org/10.1073/pnas.0438010100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12644700"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12644700"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Wendong Huang, Jun Zhang, Steven S Chua, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Induction of bilirubin clearance by the constitutive androstane receptor (CAR)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0630614100"}], "href": "https://doi.org/10.1073/pnas.0630614100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12644704"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12644704"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Wendong Huang, Jun Zhang, Michele Washington, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2004-0520"}], "href": "https://doi.org/10.1210/me.2004-0520"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15831521"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15831521"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Bryan Goodwin, Ecushla Hodgson, Daniel J D'Costa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.62.2.359"}], "href": "https://doi.org/10.1124/mol.62.2.359"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12130689"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12130689"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Stephen S Ferguson, Edward L LeCluyse, Masahiko Negishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.62.3.737"}], "href": "https://doi.org/10.1124/mol.62.3.737"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12181452"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12181452"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Oliver Burk, Ina Koch, Judy Raucy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M404949200"}], "href": "https://doi.org/10.1074/jbc.M404949200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15252010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15252010"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Stephen S Ferguson, Yuping Chen, Edward L LeCluyse, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.105.013169"}], "href": "https://doi.org/10.1124/mol.105.013169"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15933212"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15933212"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Eric Assenat, Sabine Gerbal-Chaloin, Dominique Larrey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.20387"}], "href": "https://doi.org/10.1002/hep.20387"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15382119"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15382119"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Linhao Li, Joseph D Stanton, Antonia H Tolson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharm Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11095-008-9788-8"}], "href": "https://doi.org/10.1007/s11095-008-9788-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19034627"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19034627"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Kazuma Kiyotani, Taisei Mushiroda, Michiaki Kubo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1349-7006.2008.00765.x"}], "href": "https://doi.org/10.1111/j.1349-7006.2008.00765.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18294295"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18294295"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Christoph Wyen, Heidy Hendra, Marco Siccardi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Antimicrob Chemother (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jac/dkr272"}], "href": "https://doi.org/10.1093/jac/dkr272"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21715435"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21715435"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Claudia P Cortes, Marco Siccardi, Ammara Chaikan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Correlates of efavirenz exposure in Chilean patients affected with human immunodeficiency virus reveals a novel association with a polymorphism in the constitutive androstane receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ther Drug Monit (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FTD.0b013e318274197e"}], "href": "https://doi.org/10.1097/FTD.0b013e318274197e"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23172109"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23172109"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Matthew Wortham, Maciej Czerwinski, Lin He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.107.016436"}], "href": "https://doi.org/10.1124/dmd.107.016436"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17576804"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17576804"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yoshihiro Konno, Masahiko Negishi, Susumu Kodama "}, {"type": "b", "children": [{"type": "t", "text": "The roles of nuclear receptors CAR and PXR in hepatic energy metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Pharmacokinet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2133/dmpk.23.8"}], "href": "https://doi.org/10.2133/dmpk.23.8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18305370"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18305370"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jean Marc Pascussi, Maryvonne Busson-Le Coniat, Patrick Maurel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2002-0244"}], "href": "https://doi.org/10.1210/me.2002-0244"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12511605"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12511605"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Takuma Shiraki, Noriko Sakai, Eiko Kanaya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-activated receptor gamma coactivator-1 alpha. A possible link between xenobiotic response and nutritional state."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M212859200"}], "href": "https://doi.org/10.1074/jbc.M212859200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12551939"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12551939"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Scott S Auerbach, Richard Ramsden, Matthew A Stoner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alternatively spliced isoforms of the human constitutive androstane receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkg419"}], "href": "https://doi.org/10.1093/nar/gkg419"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12799447"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12799447"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Yuping Chen, Grace Kissling, Masahiko Negishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The nuclear receptors constitutive androstane receptor and pregnane X receptor cross-talk with hepatic nuclear factor 4alpha to synergistically activate the human CYP2C9 promoter."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pharmacol Exp Ther (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/jpet.105.087072"}], "href": "https://doi.org/10.1124/jpet.105.087072"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15919766"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15919766"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Xinrong Chen, Jimei Zhang, Sharon M Baker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human constitutive androstane receptor mediated methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.tox.2006.12.019"}], "href": "https://doi.org/10.1016/j.tox.2006.12.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17276571"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17276571"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Shingo Mutoh, Makoto Osabe, Kaoru Inoue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.048108"}], "href": "https://doi.org/10.1074/jbc.M109.048108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19858220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19858220"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Wendong Huang, Jun Zhang, Ping Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2004-0046"}], "href": "https://doi.org/10.1210/me.2004-0046"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15272053"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15272053"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Gyesik Min, Hwajin Kim, Yangjin Bae, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibitory cross-talk between estrogen receptor (ER) and constitutively activated androstane receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching p160 coactivators."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M205239200"}], "href": "https://doi.org/10.1074/jbc.M205239200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12114525"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12114525"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Barbara Renga, Marco Migliorati, Andrea Mencarelli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagrm.2011.01.008"}], "href": "https://doi.org/10.1016/j.bbagrm.2011.01.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21296199"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21296199"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Gary N Y Chan, Md Tozammel Hoque, Carolyn L Cummins, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurochem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1471-4159.2011.07288.x"}], "href": "https://doi.org/10.1111/j.1471-4159.2011.07288.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21517853"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21517853"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "A A Takwi, Y-M Wang, J Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2013.330"}], "href": "https://doi.org/10.1038/onc.2013.330"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23934188"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23934188"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Maya Pascual, M José Gómez-Lechón, José V Castell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ATF5 is a highly abundant liver-enriched transcription factor that cooperates with constitutive androstane receptor in the transactivation of CYP2B6: implications in hepatic stress responses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.107.019380"}], "href": "https://doi.org/10.1124/dmd.107.019380"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18332083"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18332083"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Lu Zhang, Xiaoqiao Liu, Xuegong Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Genomics (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00438-015-1163-y"}], "href": "https://doi.org/10.1007/s00438-015-1163-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26711644"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26711644"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Jatinder K Lamba "}, {"type": "b", "children": [{"type": "t", "text": "Pharmacogenetics of the constitutive androstane receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/14622416.9.1.71"}], "href": "https://doi.org/10.2217/14622416.9.1.71"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18154449"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18154449"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Kaoru Inoue, Masahiko Negishi "}, {"type": "b", "children": [{"type": "t", "text": "Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P450 2B6 gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M800729200"}], "href": "https://doi.org/10.1074/jbc.M800729200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18303024"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18303024"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Marta Benet, Agustín Lahoz, Carla Guzmán, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CCAAT/enhancer-binding protein alpha (C/EBPalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha) synergistically cooperate with constitutive androstane receptor to transactivate the human cytochrome P450 2B6 (CYP2B6) gene: application to the development of a metabolically competent human hepatic cell model."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.118364"}], "href": "https://doi.org/10.1074/jbc.M110.118364"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20622021"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20622021"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Ryota Shizu, Sawako Shindo, Takemi Yoshida, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-122 down-regulation is involved in phenobarbital-mediated activation of the constitutive androstane receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0041291"}], "href": "https://doi.org/10.1371/journal.pone.0041291"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22815988"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22815988"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Sana-Kay Whyte-Allman, Md Tozammel Hoque, Mohammad-Ali Jenabian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pharmacol Exp Ther (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/jpet.117.243584"}], "href": "https://doi.org/10.1124/jpet.117.243584"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28970358"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28970358"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Benjamin A Kandel, Maria Thomas, Stefan Winter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagrm.2016.03.007"}], "href": "https://doi.org/10.1016/j.bbagrm.2016.03.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26994748"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26994748"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Martine Daujat-Chavanieu, Sabine Gerbal-Chaloin "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of CAR and PXR Expression in Health and Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cells (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/cells9112395"}], "href": "https://doi.org/10.3390/cells9112395"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33142929"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33142929"}]}]}]}
|
| Synonyms | MB67 |
| Proteins | NR1I3_HUMAN |
| NCBI Gene ID | 9970 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NR1I3 has 5,818 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 114 datasets.
Click the + buttons to view associations for NR1I3 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NR1I3 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of NR1I3 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NR1I3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of NR1I3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of NR1I3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Biocarta Pathways | pathways involving NR1I3 protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of NR1I3 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NR1I3 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NR1I3 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of NR1I3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of NR1I3 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of NR1I3 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with NR1I3 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NR1I3 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of NR1I3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of NR1I3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NR1I3 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing NR1I3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing NR1I3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing NR1I3 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with NR1I3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with NR1I3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of NR1I3 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with NR1I3 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with NR1I3 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with NR1I3 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by NR1I3 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with NR1I3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with NR1I3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with NR1I3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with NR1I3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with NR1I3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with NR1I3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for NR1I3 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NR1I3 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NR1I3 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of NR1I3 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing NR1I3 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with NR1I3 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with NR1I3 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of NR1I3 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with NR1I3 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing NR1I3 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of NR1I3 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NR1I3 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of NR1I3 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NR1I3 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of NR1I3 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of NR1I3 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving NR1I3 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving NR1I3 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving NR1I3 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing NR1I3 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing NR1I3 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing NR1I3 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by NR1I3 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by NR1I3 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by NR1I3 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of NR1I3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of NR1I3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NR1I3 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding NR1I3 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with NR1I3 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with NR1I3 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of NR1I3 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for NR1I3 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of NR1I3 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of NR1I3 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of NR1I3 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NR1I3 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for NR1I3 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with NR1I3 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for NR1I3 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of NR1I3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of NR1I3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of NR1I3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate NR1I3 protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways 2026 | pathways involving NR1I3 protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate NR1I3 protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of NR1I3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of NR1I3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with NR1I3 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of NR1I3 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of NR1I3 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing NR1I3 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain NR1I3 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by NR1I3 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of NR1I3 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of NR1I3 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by NR1I3 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of NR1I3 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NURSA Protein Complexes | protein complexs containing NR1I3 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for NR1I3 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NR1I3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of NR1I3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with NR1I3 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate NR1I3 protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| PID Pathways | pathways involving NR1I3 protein from the PID Pathways dataset. | |
| Reactome Pathways 2014 | pathways involving NR1I3 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving NR1I3 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NR1I3 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of NR1I3 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of NR1I3 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with NR1I3 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of NR1I3 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of NR1I3 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of NR1I3 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of NR1I3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NR1I3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of NR1I3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with NR1I3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with NR1I3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving NR1I3 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving NR1I3 protein from the WikiPathways Pathways 2024 dataset. | |